Inactief instrument

Koers Optimer Pharmaceuticals, Inc.

Aandelen

slotkoers Nasdaq Andere beurzen
- ^USD	-

Optimer Pharmaceuticals, Inc. : Pre-Market Analysis: Inovio Pharmaceuticals Inc., Sequenom Inc., and Optimer Pharmaceuticals Inc.	04-10-13
Optimer Pharmaceuticals, Inc. : Today's Research: Inovio Pharmaceuticals Inc., Onyx Pharmaceuticals Inc., Sequenom Inc. and Optimer Pharmaceuticals Inc.	29-08-13
Optimer Pharmaceuticals, Inc. : Laboratory Permits, Pending FDA Approvals, Clinical Study Presentations, and Financial Results Release - Research Report on Illumina, Theravance, Acorda, Synta, and Optimer	12-08-13
Optimer Pharmaceuticals, Inc. : Ryan & Maniskas, LLP Announces Investigation of Optimer Pharmaceuticals, Inc.	01-08-13
Optimer Pharmaceuticals, Inc. : Optimer Reports Second Quarter 2013 Financial Results	01-08-13

Sector

	Vaira. 1 jan.	Kapi.
CSL LIMITED	+0,10%	91,42 mld.
SAMSUNG BIOLOGICS CO.,LTD.	+2,76%	41,08 mld.
BIOGEN INC.	-9,06%	34,26 mld.
UCB	+54,82%	25,27 mld.
BIOMARIN PHARMACEUTICAL INC.	-16,61%	15,27 mld.
INCYTE CORPORATION	-9,14%	12,81 mld.
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-12,11%	11,6 mld.
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-43,61%	11,42 mld.
SWEDISH ORPHAN BIOVITRUM AB	+6,37%	9,16 mld.